Literature DB >> 10785540

Oxidative metabolism of anandamide.

S H Burstein1, R G Rossetti, B Yagen, R B Zurier.   

Abstract

In addition to the well studied hydrolytic metabolism of anandamide, a number of oxidative processes are also possible. Several routes somewhat analogous to the metabolism of free arachidonic acid have been reported. These involve mediation by various lipoxygenases and COX-2 and lead to ethanolamide analogs of the prostaglandins and HETES. The physiological significance of these products is not well understood at this time. There are also preliminary data suggesting a pathway involving oxidation of the hydroxy group of anandamide to a putative metabolite, N-arachidonyl glycine (AA-gly). This molecule displays activities in experimental models that suggest that it may play a role in some of the activities attributed to its precursor, anandamide.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10785540     DOI: 10.1016/s0090-6980(00)00053-8

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  49 in total

1.  A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus.

Authors:  S J Craib; H C Ellington; R G Pertwee; R A Ross
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

2.  N-acyl taurines are anti-proliferative in prostate cancer cells.

Authors:  Vicky Chatzakos; Katharina Slätis; Tatjana Djureinovic; Thomas Helleday; Mary C Hunt
Journal:  Lipids       Date:  2011-12-11       Impact factor: 1.880

3.  Reversible lysine acetylation regulates activity of human glycine N-acyltransferase-like 2 (hGLYATL2): implications for production of glycine-conjugated signaling molecules.

Authors:  Dominik P Waluk; Filip Sucharski; Laszlo Sipos; Jerzy Silberring; Mary C Hunt
Journal:  J Biol Chem       Date:  2012-03-09       Impact factor: 5.157

Review 4.  N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets.

Authors:  Mark Connor; Chris W Vaughan; Robert J Vandenberg
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 5.  The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.

Authors:  Roger G Pertwee
Journal:  AAPS J       Date:  2005-10-24       Impact factor: 4.009

Review 6.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

Review 7.  Biosynthesis, degradation and pharmacological importance of the fatty acid amides.

Authors:  Emma K Farrell; David J Merkler
Journal:  Drug Discov Today       Date:  2008-04-03       Impact factor: 7.851

Review 8.  Cannabinoid system and cyclooxygenases inhibitors.

Authors:  H Păunescu; O A Coman; L Coman; I Ghiţă; S R Georgescu; F Drăghia; I Fulga
Journal:  J Med Life       Date:  2011-02-25

9.  Excitation of cutaneous C nociceptors by intraplantar administration of anandamide.

Authors:  Carl Potenzieri; Thaddeus S Brink; Donald A Simone
Journal:  Brain Res       Date:  2009-03-10       Impact factor: 3.252

Review 10.  Dynamic regulation of the endocannabinoid system: implications for analgesia.

Authors:  Devi Rani Sagar; A Gemma Gaw; Bright N Okine; Stephen G Woodhams; Amy Wong; David A Kendall; Victoria Chapman
Journal:  Mol Pain       Date:  2009-10-08       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.